oxidopamine has been researched along with Cacosmia in 3 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, W | 1 |
| Sun, C | 1 |
| Shao, Y | 1 |
| Zhou, Z | 1 |
| Hou, Y | 1 |
| Li, A | 1 |
| Wang, T | 1 |
| Duan, SJ | 1 |
| Wang, SY | 1 |
| Lu, Y | 1 |
| Zhu, Q | 1 |
| Wang, LJ | 1 |
| Han, B | 1 |
| Höglinger, GU | 1 |
| Alvarez-Fischer, D | 1 |
| Arias-Carrión, O | 1 |
| Djufri, M | 1 |
| Windolph, A | 1 |
| Keber, U | 1 |
| Borta, A | 1 |
| Ries, V | 1 |
| Schwarting, RK | 1 |
| Scheller, D | 1 |
| Oertel, WH | 1 |
3 other studies available for oxidopamine and Cacosmia
| Article | Year |
|---|---|
Partial depletion of dopaminergic neurons in the substantia nigra impairs olfaction and alters neural activity in the olfactory bulb.
Topics: Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Humans; Male; Mice; Olfaction Disor | 2019 |
Coadministration of hydroxysafflor yellow A with levodopa attenuates the dyskinesia.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antiparkinson Agents; Apomorphine; Chalcone; Disea | 2015 |
A new dopaminergic nigro-olfactory projection.
Topics: Animals; Dopamine; Dopamine Agonists; Immunohistochemistry; Male; Neural Pathways; Neural Stem Cells | 2015 |